 |
Cimeio Therapeutics
Last updated: May 09, 2024
Thomas Fuchs, CEO
Country: USA | Funding: $50M (+)
Website: http://www.cimeio.com/
Cimeio Therapeutics is applied gene editing, cellular and immunotherapy company, developing shielded-cell and immunotherapy pairs to transform treatment for rare genetic diseases, hematologic malignancies and autoimmune disorders.
Website: http://www.cimeio.com/
Cimeio Therapeutics is applied gene editing, cellular and immunotherapy company, developing shielded-cell and immunotherapy pairs to transform treatment for rare genetic diseases, hematologic malignancies and autoimmune disorders.